These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The biological diagnosis of leishmaniasis in HIV-infected patients. Deniau M; Cañavate C; Faraut-Gambarelli F; Marty P Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():115-33. PubMed ID: 14678639 [TBL] [Abstract][Full Text] [Related]
8. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences. Ali A Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830 [TBL] [Abstract][Full Text] [Related]
9. Immunobiology of leishmaniasis. Sharma U; Singh S Indian J Exp Biol; 2009 Jun; 47(6):412-23. PubMed ID: 19634705 [TBL] [Abstract][Full Text] [Related]
10. Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. DiPiro JT Pharmacotherapy; 1997; 17(2):205-23. PubMed ID: 9085311 [TBL] [Abstract][Full Text] [Related]
11. TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection. Paul J; Naskar K; Chowdhury S; Alam MN; Chakraborti T; De T Indian J Biochem Biophys; 2014 Dec; 51(6):531-41. PubMed ID: 25823227 [TBL] [Abstract][Full Text] [Related]
13. Leishmania/HIV co-infection in Brazil: an appraisal. Rabello A; Orsini M; Disch J Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():17-28. PubMed ID: 14678630 [TBL] [Abstract][Full Text] [Related]
14. Leishmania/HIV co-infections: epidemiology in Europe. Desjeux P; Alvar J Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():3-15. PubMed ID: 14678629 [TBL] [Abstract][Full Text] [Related]
15. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Mazumdar T; Anam K; Ali N Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644 [TBL] [Abstract][Full Text] [Related]
16. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients. García-García JA; Martín-Sánchez J; Gállego M; Rivero-Román A; Camacho A; Riera C; Morillas-Márquez F; Vergara S; Macías J; Pineda JA J Clin Microbiol; 2006 Dec; 44(12):4455-8. PubMed ID: 17050814 [TBL] [Abstract][Full Text] [Related]
17. Regulator and effector functions of T-cell subsets in human Leishmania infections. Kemp M APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493 [TBL] [Abstract][Full Text] [Related]
18. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861 [TBL] [Abstract][Full Text] [Related]
19. Role of chemokines in Leishmania infection. Roychoudhury K; Roy S Curr Mol Med; 2004 Sep; 4(6):691-6. PubMed ID: 15357217 [TBL] [Abstract][Full Text] [Related]
20. Cytokine-producing T cell subsets in human leishmaniasis. Kemp K Arch Immunol Ther Exp (Warsz); 2000; 48(3):173-6. PubMed ID: 10912621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]